Label: REVERSE BRIGHTENING DEFENSE FLUID- avobenzone, homosalate, octocrylene, octisalate lotion
- NDC Code(s): 14222-2300-1, 14222-2300-2, 14222-2300-3
- Packager: Rodan & Fields
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated December 4, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active Ingredients
- Purpose
-
Uses
- Helps prevent sunburn.
- When used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun.
- Warnings
-
Directions
- Every AM, apply liberally and evenly over face + neck 15 minutes before sun exposure.
- Reapply at least every 2 hours.
- Use a water-resistant sunscreen if swimming or sweating.
- Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun
protection measures including:
- Limit time in the sun, especially from 10 a.m-2 p.m.
- Wear long-sleeve shirts, pants, hats and sunglasses.
- Children under 6 months: Ask a doctor.
-
Inactive Ingredients
Adenosine, Aminomethyl Propanol, Aqua/Eau/Water, Benzyl Alcohol, Butylene Glycol, C12-15 Alkyl Benzoate, Calcium Gluconate, Citral, Citric Acid, Cynara Scolymus (Artichoke) Leaf Extract, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Dipotassium Glycyrrhizate, Fragrance/Parfum, Gluconolactone, Glycerin, Glycine Soja (Soybean) Oil, Hydrogenated Lecithin, Limonene, Linalool, Methyl Carboxymethylphenyl Aminocarboxypropylphosphonate, Phenoxyethanol, Propanediol, Rosmarinic Acid, Rutin, Sesamum Indicum (Sesame) Seed Extract, Silica, Sodium Benzoate, Sodium Carbomer, Titanium Dioxide (Cl 77891), Tocopherol, Xanthan Gum.
- Other Information
- Questions?
- Principal Display Panel - 30 mL Carton Label
- Principal Display Panel - 30 mL Tube Label
-
INGREDIENTS AND APPEARANCE
REVERSE BRIGHTENING DEFENSE FLUID
avobenzone, homosalate, octocrylene, octisalate lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:14222-2300 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 0.028 g in 1 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 0.093 g in 1 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 0.061 g in 1 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 0.0467 g in 1 mL Inactive Ingredients Ingredient Name Strength ADENOSINE (UNII: K72T3FS567) AMINOMETHYLPROPANOL (UNII: LU49E6626Q) BENZYL ALCOHOL (UNII: LKG8494WBH) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ) CALCIUM GLUCONATE (UNII: SQE6VB453K) CARBOXYPOLYMETHYLENE (UNII: 0A5MM307FC) CITRAL (UNII: T7EU0O9VPP) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) CYNARA SCOLYMUS LEAF (UNII: B71UA545DE) DIMETHICONE (UNII: 92RU3N3Y1O) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX) GLUCONOLACTONE (UNII: WQ29KQ9POT) GLYCERIN (UNII: PDC6A3C0OX) HYDROGENATED SOYBEAN LECITHIN (UNII: H1109Z9J4N) LIMONENE, (+)- (UNII: GFD7C86Q1W) LINALOOL, (+/-)- (UNII: D81QY6I88E) PHENOXYETHANOL (UNII: HIE492ZZ3T) PROPANEDIOL (UNII: 5965N8W85T) ROSMARINIC ACID (UNII: MQE6XG29YI) RUTIN (UNII: 5G06TVY3R7) SESAME SEED (UNII: 7Y1255HVXR) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) SODIUM BENZOATE (UNII: OJ245FE5EU) SOYBEAN OIL (UNII: 241ATL177A) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) TOCOPHEROL (UNII: R0ZB2556P8) WATER (UNII: 059QF0KO0R) XANTHAN GUM (UNII: TTV12P4NEE) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:14222-2300-1 1 in 1 CARTON 03/09/2021 1 30 mL in 1 TUBE; Type 0: Not a Combination Product 2 NDC:14222-2300-2 1 in 1 CARTON 06/01/2021 2 7 mL in 1 TUBE; Type 0: Not a Combination Product 3 NDC:14222-2300-3 2 mL in 1 PACKET; Type 0: Not a Combination Product 04/12/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 03/09/2021 Labeler - Rodan & Fields (051659584)